m Search Results


98
ATCC monoclonal antibody m1 42 3 9 8
Monoclonal Antibody M1 42 3 9 8, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monoclonal antibody m1 42 3 9 8/product/ATCC
Average 98 stars, based on 1 article reviews
monoclonal antibody m1 42 3 9 8 - by Bioz Stars, 2026-04
98/100 stars
  Buy from Supplier

95
Chem Impex International cefazolin sodium salt
Cefazolin Sodium Salt, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cefazolin sodium salt/product/Chem Impex International
Average 95 stars, based on 1 article reviews
cefazolin sodium salt - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

93
Bethyl anti rpb1 antibody
a, Schematic representation of Damage-seq and PADD-seq. For Damage-seq, genomic DNA extracted from UV-irradiated cells are sonicated and ligated to the first adaptor, followed by immunoprecipitation with the lesion-specific antibody. The precise sites of the lesions are determined by the stalling of primer extension with high-fidelity DNA polymerase. After the ligation of the second adaptor, the primer extension products are PCR-amplified and sequenced. For PADD-seq, PolII-associated DNA are enriched by regular chromatin- immunoprecipitation (ChIP) with an <t>anti-pan-RPB1</t> antibody. Purified DNA fragments are subjected to Damage-seq. b, Diagram of the experimental design for the measurement of TCR (by Damage-seq) and PolII-CPD interaction (by PADD-seq). c, Meta-gene analysis of PADD-seq signals around TSSs and TESs for active genes longer than 50 kb ( n = 2790) under indicated conditions. d, Quantification of PolII retention on damage sites by relative change of PADD-seq signals from 0.5 h to 2 h on each gene. Active genes longer than 20 kb were selected ( n = 4488). e, Meta-gene analysis of Damage-seq signals around TSSs for active genes longer than 50 kb ( n = 2790) under indicated conditions. Cells were collected immediately (0 h) or at 8 h after UV irradiation. Fraction CPDs remaining was calculated as the ratio of 8 h to 0 h. f, Violin plots of relative Damage-seq signals on each active gene ( n = 6406). Log2 value of the ratio of fraction CPDs remaining on TS to that on NTS was calculated. P value was calculated using two-tailed paired Student’s t -test for (d) and (f) . See also Supplementary Fig. 1 and 2. Source data are provided as a Source Data file.
Anti Rpb1 Antibody, supplied by Bethyl, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti rpb1 antibody/product/Bethyl
Average 93 stars, based on 1 article reviews
anti rpb1 antibody - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

96
Bethyl anti smc1
a, Schematic representation of Damage-seq and PADD-seq. For Damage-seq, genomic DNA extracted from UV-irradiated cells are sonicated and ligated to the first adaptor, followed by immunoprecipitation with the lesion-specific antibody. The precise sites of the lesions are determined by the stalling of primer extension with high-fidelity DNA polymerase. After the ligation of the second adaptor, the primer extension products are PCR-amplified and sequenced. For PADD-seq, PolII-associated DNA are enriched by regular chromatin- immunoprecipitation (ChIP) with an <t>anti-pan-RPB1</t> antibody. Purified DNA fragments are subjected to Damage-seq. b, Diagram of the experimental design for the measurement of TCR (by Damage-seq) and PolII-CPD interaction (by PADD-seq). c, Meta-gene analysis of PADD-seq signals around TSSs and TESs for active genes longer than 50 kb ( n = 2790) under indicated conditions. d, Quantification of PolII retention on damage sites by relative change of PADD-seq signals from 0.5 h to 2 h on each gene. Active genes longer than 20 kb were selected ( n = 4488). e, Meta-gene analysis of Damage-seq signals around TSSs for active genes longer than 50 kb ( n = 2790) under indicated conditions. Cells were collected immediately (0 h) or at 8 h after UV irradiation. Fraction CPDs remaining was calculated as the ratio of 8 h to 0 h. f, Violin plots of relative Damage-seq signals on each active gene ( n = 6406). Log2 value of the ratio of fraction CPDs remaining on TS to that on NTS was calculated. P value was calculated using two-tailed paired Student’s t -test for (d) and (f) . See also Supplementary Fig. 1 and 2. Source data are provided as a Source Data file.
Anti Smc1, supplied by Bethyl, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti smc1/product/Bethyl
Average 96 stars, based on 1 article reviews
anti smc1 - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier

96
New England Biolabs moloney murine leukemia virus reverse transcriptase
a, Schematic representation of Damage-seq and PADD-seq. For Damage-seq, genomic DNA extracted from UV-irradiated cells are sonicated and ligated to the first adaptor, followed by immunoprecipitation with the lesion-specific antibody. The precise sites of the lesions are determined by the stalling of primer extension with high-fidelity DNA polymerase. After the ligation of the second adaptor, the primer extension products are PCR-amplified and sequenced. For PADD-seq, PolII-associated DNA are enriched by regular chromatin- immunoprecipitation (ChIP) with an <t>anti-pan-RPB1</t> antibody. Purified DNA fragments are subjected to Damage-seq. b, Diagram of the experimental design for the measurement of TCR (by Damage-seq) and PolII-CPD interaction (by PADD-seq). c, Meta-gene analysis of PADD-seq signals around TSSs and TESs for active genes longer than 50 kb ( n = 2790) under indicated conditions. d, Quantification of PolII retention on damage sites by relative change of PADD-seq signals from 0.5 h to 2 h on each gene. Active genes longer than 20 kb were selected ( n = 4488). e, Meta-gene analysis of Damage-seq signals around TSSs for active genes longer than 50 kb ( n = 2790) under indicated conditions. Cells were collected immediately (0 h) or at 8 h after UV irradiation. Fraction CPDs remaining was calculated as the ratio of 8 h to 0 h. f, Violin plots of relative Damage-seq signals on each active gene ( n = 6406). Log2 value of the ratio of fraction CPDs remaining on TS to that on NTS was calculated. P value was calculated using two-tailed paired Student’s t -test for (d) and (f) . See also Supplementary Fig. 1 and 2. Source data are provided as a Source Data file.
Moloney Murine Leukemia Virus Reverse Transcriptase, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/moloney murine leukemia virus reverse transcriptase/product/New England Biolabs
Average 96 stars, based on 1 article reviews
moloney murine leukemia virus reverse transcriptase - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier

94
Bethyl pbrm1
a, Schematic representation of Damage-seq and PADD-seq. For Damage-seq, genomic DNA extracted from UV-irradiated cells are sonicated and ligated to the first adaptor, followed by immunoprecipitation with the lesion-specific antibody. The precise sites of the lesions are determined by the stalling of primer extension with high-fidelity DNA polymerase. After the ligation of the second adaptor, the primer extension products are PCR-amplified and sequenced. For PADD-seq, PolII-associated DNA are enriched by regular chromatin- immunoprecipitation (ChIP) with an <t>anti-pan-RPB1</t> antibody. Purified DNA fragments are subjected to Damage-seq. b, Diagram of the experimental design for the measurement of TCR (by Damage-seq) and PolII-CPD interaction (by PADD-seq). c, Meta-gene analysis of PADD-seq signals around TSSs and TESs for active genes longer than 50 kb ( n = 2790) under indicated conditions. d, Quantification of PolII retention on damage sites by relative change of PADD-seq signals from 0.5 h to 2 h on each gene. Active genes longer than 20 kb were selected ( n = 4488). e, Meta-gene analysis of Damage-seq signals around TSSs for active genes longer than 50 kb ( n = 2790) under indicated conditions. Cells were collected immediately (0 h) or at 8 h after UV irradiation. Fraction CPDs remaining was calculated as the ratio of 8 h to 0 h. f, Violin plots of relative Damage-seq signals on each active gene ( n = 6406). Log2 value of the ratio of fraction CPDs remaining on TS to that on NTS was calculated. P value was calculated using two-tailed paired Student’s t -test for (d) and (f) . See also Supplementary Fig. 1 and 2. Source data are provided as a Source Data file.
Pbrm1, supplied by Bethyl, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pbrm1/product/Bethyl
Average 94 stars, based on 1 article reviews
pbrm1 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

96
Vector Laboratories mouse
a, Schematic representation of Damage-seq and PADD-seq. For Damage-seq, genomic DNA extracted from UV-irradiated cells are sonicated and ligated to the first adaptor, followed by immunoprecipitation with the lesion-specific antibody. The precise sites of the lesions are determined by the stalling of primer extension with high-fidelity DNA polymerase. After the ligation of the second adaptor, the primer extension products are PCR-amplified and sequenced. For PADD-seq, PolII-associated DNA are enriched by regular chromatin- immunoprecipitation (ChIP) with an <t>anti-pan-RPB1</t> antibody. Purified DNA fragments are subjected to Damage-seq. b, Diagram of the experimental design for the measurement of TCR (by Damage-seq) and PolII-CPD interaction (by PADD-seq). c, Meta-gene analysis of PADD-seq signals around TSSs and TESs for active genes longer than 50 kb ( n = 2790) under indicated conditions. d, Quantification of PolII retention on damage sites by relative change of PADD-seq signals from 0.5 h to 2 h on each gene. Active genes longer than 20 kb were selected ( n = 4488). e, Meta-gene analysis of Damage-seq signals around TSSs for active genes longer than 50 kb ( n = 2790) under indicated conditions. Cells were collected immediately (0 h) or at 8 h after UV irradiation. Fraction CPDs remaining was calculated as the ratio of 8 h to 0 h. f, Violin plots of relative Damage-seq signals on each active gene ( n = 6406). Log2 value of the ratio of fraction CPDs remaining on TS to that on NTS was calculated. P value was calculated using two-tailed paired Student’s t -test for (d) and (f) . See also Supplementary Fig. 1 and 2. Source data are provided as a Source Data file.
Mouse, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse/product/Vector Laboratories
Average 96 stars, based on 1 article reviews
mouse - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier

pp16  (Bethyl)
93
Bethyl pp16
a, Schematic representation of Damage-seq and PADD-seq. For Damage-seq, genomic DNA extracted from UV-irradiated cells are sonicated and ligated to the first adaptor, followed by immunoprecipitation with the lesion-specific antibody. The precise sites of the lesions are determined by the stalling of primer extension with high-fidelity DNA polymerase. After the ligation of the second adaptor, the primer extension products are PCR-amplified and sequenced. For PADD-seq, PolII-associated DNA are enriched by regular chromatin- immunoprecipitation (ChIP) with an <t>anti-pan-RPB1</t> antibody. Purified DNA fragments are subjected to Damage-seq. b, Diagram of the experimental design for the measurement of TCR (by Damage-seq) and PolII-CPD interaction (by PADD-seq). c, Meta-gene analysis of PADD-seq signals around TSSs and TESs for active genes longer than 50 kb ( n = 2790) under indicated conditions. d, Quantification of PolII retention on damage sites by relative change of PADD-seq signals from 0.5 h to 2 h on each gene. Active genes longer than 20 kb were selected ( n = 4488). e, Meta-gene analysis of Damage-seq signals around TSSs for active genes longer than 50 kb ( n = 2790) under indicated conditions. Cells were collected immediately (0 h) or at 8 h after UV irradiation. Fraction CPDs remaining was calculated as the ratio of 8 h to 0 h. f, Violin plots of relative Damage-seq signals on each active gene ( n = 6406). Log2 value of the ratio of fraction CPDs remaining on TS to that on NTS was calculated. P value was calculated using two-tailed paired Student’s t -test for (d) and (f) . See also Supplementary Fig. 1 and 2. Source data are provided as a Source Data file.
Pp16, supplied by Bethyl, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pp16/product/Bethyl
Average 93 stars, based on 1 article reviews
pp16 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

95
Bethyl γ h2ax
a, Schematic representation of Damage-seq and PADD-seq. For Damage-seq, genomic DNA extracted from UV-irradiated cells are sonicated and ligated to the first adaptor, followed by immunoprecipitation with the lesion-specific antibody. The precise sites of the lesions are determined by the stalling of primer extension with high-fidelity DNA polymerase. After the ligation of the second adaptor, the primer extension products are PCR-amplified and sequenced. For PADD-seq, PolII-associated DNA are enriched by regular chromatin- immunoprecipitation (ChIP) with an <t>anti-pan-RPB1</t> antibody. Purified DNA fragments are subjected to Damage-seq. b, Diagram of the experimental design for the measurement of TCR (by Damage-seq) and PolII-CPD interaction (by PADD-seq). c, Meta-gene analysis of PADD-seq signals around TSSs and TESs for active genes longer than 50 kb ( n = 2790) under indicated conditions. d, Quantification of PolII retention on damage sites by relative change of PADD-seq signals from 0.5 h to 2 h on each gene. Active genes longer than 20 kb were selected ( n = 4488). e, Meta-gene analysis of Damage-seq signals around TSSs for active genes longer than 50 kb ( n = 2790) under indicated conditions. Cells were collected immediately (0 h) or at 8 h after UV irradiation. Fraction CPDs remaining was calculated as the ratio of 8 h to 0 h. f, Violin plots of relative Damage-seq signals on each active gene ( n = 6406). Log2 value of the ratio of fraction CPDs remaining on TS to that on NTS was calculated. P value was calculated using two-tailed paired Student’s t -test for (d) and (f) . See also Supplementary Fig. 1 and 2. Source data are provided as a Source Data file.
γ H2ax, supplied by Bethyl, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/γ h2ax/product/Bethyl
Average 95 stars, based on 1 article reviews
γ h2ax - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

92
Bethyl antibodies against cbp20
a, Schematic representation of Damage-seq and PADD-seq. For Damage-seq, genomic DNA extracted from UV-irradiated cells are sonicated and ligated to the first adaptor, followed by immunoprecipitation with the lesion-specific antibody. The precise sites of the lesions are determined by the stalling of primer extension with high-fidelity DNA polymerase. After the ligation of the second adaptor, the primer extension products are PCR-amplified and sequenced. For PADD-seq, PolII-associated DNA are enriched by regular chromatin- immunoprecipitation (ChIP) with an <t>anti-pan-RPB1</t> antibody. Purified DNA fragments are subjected to Damage-seq. b, Diagram of the experimental design for the measurement of TCR (by Damage-seq) and PolII-CPD interaction (by PADD-seq). c, Meta-gene analysis of PADD-seq signals around TSSs and TESs for active genes longer than 50 kb ( n = 2790) under indicated conditions. d, Quantification of PolII retention on damage sites by relative change of PADD-seq signals from 0.5 h to 2 h on each gene. Active genes longer than 20 kb were selected ( n = 4488). e, Meta-gene analysis of Damage-seq signals around TSSs for active genes longer than 50 kb ( n = 2790) under indicated conditions. Cells were collected immediately (0 h) or at 8 h after UV irradiation. Fraction CPDs remaining was calculated as the ratio of 8 h to 0 h. f, Violin plots of relative Damage-seq signals on each active gene ( n = 6406). Log2 value of the ratio of fraction CPDs remaining on TS to that on NTS was calculated. P value was calculated using two-tailed paired Student’s t -test for (d) and (f) . See also Supplementary Fig. 1 and 2. Source data are provided as a Source Data file.
Antibodies Against Cbp20, supplied by Bethyl, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies against cbp20/product/Bethyl
Average 92 stars, based on 1 article reviews
antibodies against cbp20 - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier

96
Vector Laboratories biotinylated anti mouse antibody
a, Schematic representation of Damage-seq and PADD-seq. For Damage-seq, genomic DNA extracted from UV-irradiated cells are sonicated and ligated to the first adaptor, followed by immunoprecipitation with the lesion-specific antibody. The precise sites of the lesions are determined by the stalling of primer extension with high-fidelity DNA polymerase. After the ligation of the second adaptor, the primer extension products are PCR-amplified and sequenced. For PADD-seq, PolII-associated DNA are enriched by regular chromatin- immunoprecipitation (ChIP) with an <t>anti-pan-RPB1</t> antibody. Purified DNA fragments are subjected to Damage-seq. b, Diagram of the experimental design for the measurement of TCR (by Damage-seq) and PolII-CPD interaction (by PADD-seq). c, Meta-gene analysis of PADD-seq signals around TSSs and TESs for active genes longer than 50 kb ( n = 2790) under indicated conditions. d, Quantification of PolII retention on damage sites by relative change of PADD-seq signals from 0.5 h to 2 h on each gene. Active genes longer than 20 kb were selected ( n = 4488). e, Meta-gene analysis of Damage-seq signals around TSSs for active genes longer than 50 kb ( n = 2790) under indicated conditions. Cells were collected immediately (0 h) or at 8 h after UV irradiation. Fraction CPDs remaining was calculated as the ratio of 8 h to 0 h. f, Violin plots of relative Damage-seq signals on each active gene ( n = 6406). Log2 value of the ratio of fraction CPDs remaining on TS to that on NTS was calculated. P value was calculated using two-tailed paired Student’s t -test for (d) and (f) . See also Supplementary Fig. 1 and 2. Source data are provided as a Source Data file.
Biotinylated Anti Mouse Antibody, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/biotinylated anti mouse antibody/product/Vector Laboratories
Average 96 stars, based on 1 article reviews
biotinylated anti mouse antibody - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier

kap1  (Bethyl)
94
Bethyl kap1
a, Schematic representation of Damage-seq and PADD-seq. For Damage-seq, genomic DNA extracted from UV-irradiated cells are sonicated and ligated to the first adaptor, followed by immunoprecipitation with the lesion-specific antibody. The precise sites of the lesions are determined by the stalling of primer extension with high-fidelity DNA polymerase. After the ligation of the second adaptor, the primer extension products are PCR-amplified and sequenced. For PADD-seq, PolII-associated DNA are enriched by regular chromatin- immunoprecipitation (ChIP) with an <t>anti-pan-RPB1</t> antibody. Purified DNA fragments are subjected to Damage-seq. b, Diagram of the experimental design for the measurement of TCR (by Damage-seq) and PolII-CPD interaction (by PADD-seq). c, Meta-gene analysis of PADD-seq signals around TSSs and TESs for active genes longer than 50 kb ( n = 2790) under indicated conditions. d, Quantification of PolII retention on damage sites by relative change of PADD-seq signals from 0.5 h to 2 h on each gene. Active genes longer than 20 kb were selected ( n = 4488). e, Meta-gene analysis of Damage-seq signals around TSSs for active genes longer than 50 kb ( n = 2790) under indicated conditions. Cells were collected immediately (0 h) or at 8 h after UV irradiation. Fraction CPDs remaining was calculated as the ratio of 8 h to 0 h. f, Violin plots of relative Damage-seq signals on each active gene ( n = 6406). Log2 value of the ratio of fraction CPDs remaining on TS to that on NTS was calculated. P value was calculated using two-tailed paired Student’s t -test for (d) and (f) . See also Supplementary Fig. 1 and 2. Source data are provided as a Source Data file.
Kap1, supplied by Bethyl, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/kap1/product/Bethyl
Average 94 stars, based on 1 article reviews
kap1 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

Image Search Results


a, Schematic representation of Damage-seq and PADD-seq. For Damage-seq, genomic DNA extracted from UV-irradiated cells are sonicated and ligated to the first adaptor, followed by immunoprecipitation with the lesion-specific antibody. The precise sites of the lesions are determined by the stalling of primer extension with high-fidelity DNA polymerase. After the ligation of the second adaptor, the primer extension products are PCR-amplified and sequenced. For PADD-seq, PolII-associated DNA are enriched by regular chromatin- immunoprecipitation (ChIP) with an anti-pan-RPB1 antibody. Purified DNA fragments are subjected to Damage-seq. b, Diagram of the experimental design for the measurement of TCR (by Damage-seq) and PolII-CPD interaction (by PADD-seq). c, Meta-gene analysis of PADD-seq signals around TSSs and TESs for active genes longer than 50 kb ( n = 2790) under indicated conditions. d, Quantification of PolII retention on damage sites by relative change of PADD-seq signals from 0.5 h to 2 h on each gene. Active genes longer than 20 kb were selected ( n = 4488). e, Meta-gene analysis of Damage-seq signals around TSSs for active genes longer than 50 kb ( n = 2790) under indicated conditions. Cells were collected immediately (0 h) or at 8 h after UV irradiation. Fraction CPDs remaining was calculated as the ratio of 8 h to 0 h. f, Violin plots of relative Damage-seq signals on each active gene ( n = 6406). Log2 value of the ratio of fraction CPDs remaining on TS to that on NTS was calculated. P value was calculated using two-tailed paired Student’s t -test for (d) and (f) . See also Supplementary Fig. 1 and 2. Source data are provided as a Source Data file.

Journal: bioRxiv

Article Title: Coordination of transcription-coupled repair and repair-independent release of stalled RNA polymerase II in response to transcription-blocking lesions

doi: 10.1101/2024.07.07.602436

Figure Lengend Snippet: a, Schematic representation of Damage-seq and PADD-seq. For Damage-seq, genomic DNA extracted from UV-irradiated cells are sonicated and ligated to the first adaptor, followed by immunoprecipitation with the lesion-specific antibody. The precise sites of the lesions are determined by the stalling of primer extension with high-fidelity DNA polymerase. After the ligation of the second adaptor, the primer extension products are PCR-amplified and sequenced. For PADD-seq, PolII-associated DNA are enriched by regular chromatin- immunoprecipitation (ChIP) with an anti-pan-RPB1 antibody. Purified DNA fragments are subjected to Damage-seq. b, Diagram of the experimental design for the measurement of TCR (by Damage-seq) and PolII-CPD interaction (by PADD-seq). c, Meta-gene analysis of PADD-seq signals around TSSs and TESs for active genes longer than 50 kb ( n = 2790) under indicated conditions. d, Quantification of PolII retention on damage sites by relative change of PADD-seq signals from 0.5 h to 2 h on each gene. Active genes longer than 20 kb were selected ( n = 4488). e, Meta-gene analysis of Damage-seq signals around TSSs for active genes longer than 50 kb ( n = 2790) under indicated conditions. Cells were collected immediately (0 h) or at 8 h after UV irradiation. Fraction CPDs remaining was calculated as the ratio of 8 h to 0 h. f, Violin plots of relative Damage-seq signals on each active gene ( n = 6406). Log2 value of the ratio of fraction CPDs remaining on TS to that on NTS was calculated. P value was calculated using two-tailed paired Student’s t -test for (d) and (f) . See also Supplementary Fig. 1 and 2. Source data are provided as a Source Data file.

Article Snippet: In brief, 167 μg of fragmented chromatin and 25 μg of anti-RPB1 antibody (Bethyl Laboratories, A304-405A) were incubated in RIPA buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA, 140 mM NaCl, 1% Triton X-100, 0.1% SDS and 0.1% Na-DOC) supplemented with protease inhibitors, 0.1 % BSA (Sigma) and 0.1 μg/μl tRNA (Sigma) for 2 h on a rotator at 4 °C.

Techniques: Irradiation, Sonication, Immunoprecipitation, Ligation, Amplification, Chromatin Immunoprecipitation, Purification, Two Tailed Test

a, Meta-gene analysis of Damage-seq signals around TSSs for active genes longer than 50 kb ( n = 2790) under indicated conditions. Cells were collected immediately (0 h) or at 8 h after UV irradiation. Fraction CPDs remaining was calculated as the ratio of 8 h to 0 h. Data of WT and CSB -KO cells are from our previous study . b, Violin plots of relative Damage-seq signals on each active gene ( n = 6406). Log2 value of the ratio of fraction CPDs remaining on TS to that on NTS was calculated. c, Meta-gene analysis of PADD-seq signals around TSSs and TESs for active genes longer than 50 kb ( n = 2790) under indicated conditions. d, Quantification of PolII retention on damage sites by relative change of PADD-seq signals from 0.5 h to 2 h on each gene. Active genes longer than 20 kb were selected ( n = 4488). P value was calculated using two-tailed paired Student’s t -test for (b) and (d) . e, Diagram showing that three possible fates of lesion-stalled PolII should co-exist in RPB1-K1268R cells. See also Supplementary Fig. 5. Source data are provided as a Source Data file.

Journal: bioRxiv

Article Title: Coordination of transcription-coupled repair and repair-independent release of stalled RNA polymerase II in response to transcription-blocking lesions

doi: 10.1101/2024.07.07.602436

Figure Lengend Snippet: a, Meta-gene analysis of Damage-seq signals around TSSs for active genes longer than 50 kb ( n = 2790) under indicated conditions. Cells were collected immediately (0 h) or at 8 h after UV irradiation. Fraction CPDs remaining was calculated as the ratio of 8 h to 0 h. Data of WT and CSB -KO cells are from our previous study . b, Violin plots of relative Damage-seq signals on each active gene ( n = 6406). Log2 value of the ratio of fraction CPDs remaining on TS to that on NTS was calculated. c, Meta-gene analysis of PADD-seq signals around TSSs and TESs for active genes longer than 50 kb ( n = 2790) under indicated conditions. d, Quantification of PolII retention on damage sites by relative change of PADD-seq signals from 0.5 h to 2 h on each gene. Active genes longer than 20 kb were selected ( n = 4488). P value was calculated using two-tailed paired Student’s t -test for (b) and (d) . e, Diagram showing that three possible fates of lesion-stalled PolII should co-exist in RPB1-K1268R cells. See also Supplementary Fig. 5. Source data are provided as a Source Data file.

Article Snippet: In brief, 167 μg of fragmented chromatin and 25 μg of anti-RPB1 antibody (Bethyl Laboratories, A304-405A) were incubated in RIPA buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA, 140 mM NaCl, 1% Triton X-100, 0.1% SDS and 0.1% Na-DOC) supplemented with protease inhibitors, 0.1 % BSA (Sigma) and 0.1 μg/μl tRNA (Sigma) for 2 h on a rotator at 4 °C.

Techniques: Irradiation, Two Tailed Test